Optimal Modified Extended Antibiotic Prophylaxis for Prostate Biopsy: The Addition of Two Intravenous Doses of Amikacin to Ciprofloxacin

키워드

참고문헌 (28)

1. Loeb S, "Complications after prostate biopsy: data from SEER-Medicare", J Urol, 186, pp.1830~1834 (2011)
2. Tufan ZK, "A life-threatening Escherichia coli meningitis after prostate biopsy", Urol J, 8, pp.69~71 (2011)
3. Wolf JS Jr, "Best practice policy statement on urologic surgery antimicrobial prophylaxis", J Urol, 179, pp.1379~1390 (2008)
4. Cek M, "Antibiotic prophylaxis in urology departments, 2005-2010", Eur Urol, 63, pp.386~394 (2013)
5. Feliciano J, "The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis", J Urol, 179, pp.952~955 (2008)
6. Horcajada JP, "High prevalence of extended-spectrum beta-lactamaseproducing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol", Urology, 74, pp.1195~1199 (2009)
7. Chung HS, "Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: a prospective multicenter study", Int J Urol, 25, pp.278~283 (2018)
8. Ozden E, "Incidence of acute prostatitis caused by extendedspectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy", Urology, 74, pp.119~123 (2009)
9. Batura D, "Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates", BJU Int, 107, pp.760~764 (2011)
10. Kehinde EO, "Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate", J Urol, 189, pp.911~915 (2013)
11. Adibi M, "Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis", J Urol, 189, pp.535~540 (2013)
12. Adibi M, "Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis", BJU Int, 110, pp.E86~E91 (2012)
13. Zani EL, "Antibiotic prophylaxis for transrectal prostate biopsy", Cochrane Database Syst Rev, (5), pp.CD006576~ (2011)
14. Marino K, "Comparative effectiveness of single versus combination antibiotic prophylaxis for infections after transrectal prostate biopsy", Antimicrob Agents Chemother, 59, pp.7273~7275 (2015)
15. Batura D, "Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy", BJU Int, 106, pp.1017~1020 (2010)
16. Nam RK, "Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy", J Urol, 183, pp.963~968 (2010)
17. Taylor AK, "Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care", J Urol, 187, pp.1275~1279 (2012)
18. Duplessis CA, "Rectal cultures before transrectal ultrasoundguided prostate biopsy reduce post-prostatic biopsy infection rates", Urology, 79, pp.556~561 (2012)
19. Tsu JH, "Prevalence and predictive factors of harboring fluoroquinoloneresistant and extended-spectrum -lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy", Urology, 85, pp.15~21 (2015)
20. Unnikrishnan R, "For single dosing, levofloxacin is superior to ciprofloxacin when combined with an aminoglycoside in preventing severe infections after prostate biopsy", Urology, 85, pp.1241~1246 (2015)
21. Miyazaki Y, "A prospective randomized trial comparing a combined regimen of amikacin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle biopsy", Urol J, 13, pp.2533~2540 (2016)
22. Gopal Rao G, "Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies", Int Urol Nephrol, 46, pp.309~315 (2014)
23. 손경철, "Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora", Journal of Korean Medical Science, 33(15), pp.12~22 (2018), 대한의학회
24. Kanafani ZA, "Epidemiology and risk factors for extended-spectrum betalactamase- producing organisms: a case control study at a tertiary care center in Lebanon", Am J Infect Control, 33, pp.326~332 (2005)
25. Lautenbach E, "Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes", Clin Infect Dis, 32, pp.1162~1171 (2001)
26. Hyle EP, "Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum betalactamase- producing enterobacteriaceae: variability by site of infection", Arch Intern Med, 165, pp.1375~1380 (2005)
27. Hwang EC, "Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study", Int Urol Nephrol, 47, pp.595~601 (2015)
28. Ryu JW, "Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications", Int Urol Nephrol, 48, pp.1763~1770 (2016)

관련 논문AI추천